Monotherapy for partial epilepsy: focus on levetiracetam.

Neuropsychiatric Disease and Treatment
Antonio GambardellaAldo Quattrone

Abstract

Levetiracetam (LEV), the S-enantiomer of alpha-ethyl-2-oxo-1-pyrollidine acetamide, is a recently licensed antiepileptic drug (AED) for adjunctive therapy of partial seizures. Its mechanism of action is uncertain but it exhibits a unique profile of anticonvulsant activity in models of chronic epilepsy. Five randomized, double-blind, placebo-controlled trials enrolling adult or pediatric patients with refractory partial epilepsy have demonstrated the efficacy of LEV as adjunctive therapy, with a responder rate (>/=50% reduction in seizure frequency) of 28%-45%. Long-term efficacy studies suggest retention rates of 60% after one year, with 13% of patients seizure-free for 6 months of the study and 8% seizure-free for 1 year. More recent studies illustrated successful conversion to monotherapy in patients with refractory epilepsy, and its effectiveness as a single agent in partial epilepsy. LEV has also efficacy in generalized epilepsies. Adverse effects of LEV, including somnolence, lethargy, and dizziness, are generally mild and their occurrence rate seems to be not significantly different from that observed in placebo groups. LEV also has no clinically significant pharmacokinetic interactions with other AEDs, or with commonly p...Continue Reading

References

Nov 10, 1992·European Journal of Pharmacology·A J GowerE Wülfert
Sep 3, 1998·European Journal of Pharmacology·H KlitgaardE Wülfert
Jul 24, 2001·Seizure : the Journal of the British Epilepsy Association·C ZonaD G Margineanu
Sep 21, 2001·Epilepsia·R A Radtke
Sep 21, 2001·Epilepsia·C Harden
Nov 21, 2001·Pharmacotherapy·C A Hovinga
Dec 14, 2001·Lancet·S Shorvon
Mar 7, 2002·Epilepsia·J M PellockW D Shields
Mar 7, 2002·Epilepsia·E H KossoffE P Vining
Sep 10, 2003·Neurology·M MulaJ W A S Sander
Feb 1, 2005·Epilepsia·Jacqueline French, Celestina Arrigo
Feb 8, 2005·Seizure : the Journal of the British Epilepsy Association·Taoufik M AlsaadiSarah Farias
Jan 20, 2006·Seizure : the Journal of the British Epilepsy Association·Angelo LabateAldo Quattrone
Feb 7, 2007·Neurology·M J BrodieUNKNOWN Levetiracetam Monotherapy Study Group

❮ Previous
Next ❯

Citations

Dec 3, 2014·Journal of Pharmaceutical Sciences·Jagriti NarangC S Pundir
Nov 26, 2015·The Journal of Emergency Medicine·Ayşe Kaçar BayramHüseyin Per
Dec 21, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Emilio RussoGiovambattista De Sarro
Mar 27, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Andrew I GellerDale C Strasser
Oct 18, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Jounhong Ryan ChoSeung Bong Hong
Oct 19, 2010·Brain & Development·Antonella GaglianoRosalia Silvestri
Dec 2, 2009·The American Journal of Geriatric Pharmacotherapy·Joseph P Vande GriendJacquelyn L Bainbridge
Mar 8, 2014·Reproductive Toxicology·Shahnaz Akhtar ChaudhryGideon Koren
Jan 23, 2017·Journal of Pharmaceutical Sciences·Bram HarmsenTom Leyssens
Jan 13, 2018·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M TrimboliA Labate
Jan 1, 2011·Journal of Central Nervous System Disease·Alessandro S De NadaiTanya K Murphy
Jul 30, 2018·Acta neurologica Belgica·Guray KocZeki Gokcil
Nov 17, 2020·Seizure : the Journal of the British Epilepsy Association·Valerija LamouretBernhard J Steinhoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Practice
A Pinto, Josemir W A Sander
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
H-J Meencke, S Buyle
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Ahmed A ElberrySawsan M Kurdi
© 2022 Meta ULC. All rights reserved